Class information for:
Level 1: CD73//ADENOSINE RECEPTORS//ADENOSINE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
4306 1808 48.8 90%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
236 3       ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS 48331
409 2             ADENOSINE//ADENOSINE RECEPTORS//ATP 16639
4306 1                   CD73//ADENOSINE RECEPTORS//ADENOSINE 1808

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CD73 authKW 734510 5% 50% 87
2 ADENOSINE RECEPTORS authKW 577840 12% 16% 218
3 ADENOSINE authKW 538195 24% 7% 439
4 NEW ENGLAND INFLAMMAT TISSUE PROTECT address 345829 2% 64% 32
5 MUCOSAL INFLAMMAT PROGRAM address 328862 3% 35% 56
6 A3 ADENOSINE RECEPTOR authKW 302141 2% 46% 39
7 IB MECA authKW 203341 1% 71% 17
8 ADENOSINE A3 RECEPTOR authKW 160637 2% 31% 31
9 CD39 authKW 147558 2% 22% 39
10 ECTO 5 NUCLEOTIDASE authKW 99879 2% 17% 35

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Immunology 3182 21% 0% 385
2 Pharmacology & Pharmacy 1270 18% 0% 317
3 Cell Biology 1209 15% 0% 269
4 Physiology 723 8% 0% 141
5 Hematology 712 7% 0% 123
6 Medicine, Research & Experimental 508 7% 0% 133
7 Oncology 451 10% 0% 184
8 Peripheral Vascular Diseases 311 5% 0% 83
9 Respiratory System 287 4% 0% 70
10 Biochemistry & Molecular Biology 215 14% 0% 246

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NEW ENGLAND INFLAMMAT TISSUE PROTECT 345829 2% 64% 32
2 MUCOSAL INFLAMMAT PROGRAM 328862 3% 35% 56
3 FELSENSTEIN MED CLIN TUMOR IMMUNOL 70362 0% 83% 5
4 NAZL ECCELLENZA SVILUPPO METODOL INNOVAT STUD 70362 0% 83% 5
5 TUMOR CLIN IMMUNOL 54038 0% 80% 4
6 ORGAN PROTECT PROGRAM 48667 0% 41% 7
7 IMMUNOBIOL CANC PROGRAM 42310 1% 11% 22
8 DRUG PHARMACOL SCI 41365 0% 35% 7
9 CANC INFANTIL RS 33775 0% 100% 2
10 INFLAMMAT HYPOXIA 33775 0% 100% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PURINERGIC SIGNALLING 58976 2% 9% 39
2 JOURNAL OF IMMUNOLOGY 4035 6% 0% 115
3 DRUG DEVELOPMENT RESEARCH 2994 1% 1% 23
4 FASEB JOURNAL 1878 2% 0% 33
5 JOURNAL OF LEUKOCYTE BIOLOGY 1474 1% 0% 25
6 AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY 1394 1% 0% 22
7 PHYSIOLOGICAL RESEARCH 1386 1% 1% 15
8 BRITISH JOURNAL OF PHARMACOLOGY 1314 2% 0% 38
9 ONCOIMMUNOLOGY 1116 0% 1% 8
10 MOLECULAR PHARMACOLOGY 956 1% 0% 24

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CD73 734510 5% 50% 87 Search CD73 Search CD73
2 ADENOSINE RECEPTORS 577840 12% 16% 218 Search ADENOSINE+RECEPTORS Search ADENOSINE+RECEPTORS
3 ADENOSINE 538195 24% 7% 439 Search ADENOSINE Search ADENOSINE
4 A3 ADENOSINE RECEPTOR 302141 2% 46% 39 Search A3+ADENOSINE+RECEPTOR Search A3+ADENOSINE+RECEPTOR
5 IB MECA 203341 1% 71% 17 Search IB+MECA Search IB+MECA
6 ADENOSINE A3 RECEPTOR 160637 2% 31% 31 Search ADENOSINE+A3+RECEPTOR Search ADENOSINE+A3+RECEPTOR
7 CD39 147558 2% 22% 39 Search CD39 Search CD39
8 ECTO 5 NUCLEOTIDASE 99879 2% 17% 35 Search ECTO+5+NUCLEOTIDASE Search ECTO+5+NUCLEOTIDASE
9 CL IB MECA 90060 0% 67% 8 Search CL+IB+MECA Search CL+IB+MECA
10 A2B RECEPTOR 89171 1% 41% 13 Search A2B+RECEPTOR Search A2B+RECEPTOR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ANTONIOLI, L , BLANDIZZI, C , PACHER, P , HASKO, G , (2013) IMMUNITY, INFLAMMATION AND CANCER: A LEADING ROLE FOR ADENOSINE.NATURE REVIEWS CANCER. VOL. 13. ISSUE 12. P. 842 -857 145 70% 86
2 CEKIC, C , LINDEN, J , (2016) PURINERGIC REGULATION OF THE IMMUNE SYSTEM.NATURE REVIEWS IMMUNOLOGY. VOL. 16. ISSUE 3. P. 177 -192 106 54% 17
3 BOREA, PA , VARANI, K , VINCENZI, F , BARALDI, PG , TABRIZI, MA , MERIGHI, S , GESSI, S , (2015) THE A(3) ADENOSINE RECEPTOR: HISTORY AND PERSPECTIVES.PHARMACOLOGICAL REVIEWS. VOL. 67. ISSUE 1. P. 74 -102 169 48% 23
4 BOURS, MJL , SWENNEN, ELR , DI VIRGILIO, F , CRONSTEIN, BN , DAGNELIE, PC , (2006) ADENOSINE 5 '-TRIPHOSPHATE AND ADENOSINE AS ENDOGENOUS SIGNALING MOLECULES IN IMMUNITY AND INFLAMMATION.PHARMACOLOGY & THERAPEUTICS. VOL. 112. ISSUE 2. P. 358 -404 217 32% 458
5 ALLARD, D , ALLARD, B , GAUDREAU, PO , CHROBAK, P , STAGG, J , (2016) CD73-ADENOSINE: A NEXT-GENERATION TARGET IN IMMUNO-ONCOLOGY.IMMUNOTHERAPY. VOL. 8. ISSUE 2. P. 145 -163 105 66% 4
6 HASKO, G , LINDEN, J , CRONSTEIN, B , PACHER, P , (2008) ADENOSINE RECEPTORS: THERAPEUTIC ASPECTS FOR INFLAMMATORY AND IMMUNE DISEASES.NATURE REVIEWS DRUG DISCOVERY. VOL. 7. ISSUE 9. P. 759-770 86 70% 420
7 GESSI, S , MERIGHI, S , SACCHETTO, V , SIMIONI, C , BOREA, PA , (2011) ADENOSINE RECEPTORS AND CANCER.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. VOL. 1808. ISSUE 5. P. 1400-1412 104 72% 52
8 ANTONIOLI, L , PACHER, P , VIZI, ES , HASKO, G , (2013) CD39 AND CD73 IN IMMUNITY AND INFLAMMATION.TRENDS IN MOLECULAR MEDICINE. VOL. 19. ISSUE 6. P. 355-367 86 55% 130
9 MULLER-HAEGELE, S , MULLER, L , WHITESIDE, TL , (2014) IMMUNOREGULATORY ACTIVITY OF ADENOSINE AND ITS ROLE IN HUMAN CANCER PROGRESSION.EXPERT REVIEW OF CLINICAL IMMUNOLOGY. VOL. 10. ISSUE 7. P. 897 -914 99 68% 14
10 ALLARD, B , BEAVIS, PA , DARCY, PK , STAGG, J , (2016) IMMUNOSUPPRESSIVE ACTIVITIES OF ADENOSINE IN CANCER.CURRENT OPINION IN PHARMACOLOGY. VOL. 29. ISSUE . P. 7 -16 75 78% 2

Classes with closest relation at Level 1


Rank Class id link
1 3075 MOL RECOGNIT SECT//ADENOSINE RECEPTORS//ADENOSINE RECEPTOR ANTAGONISTS
2 18367 DOXOFYLLINE//1 METHYL 3 PROPYL 7 BUTYLXANTHINE//7 THEOPHYLLINE ACETIC ACID
3 8571 NTPDASE//ECTO ATPASE//ATP DIPHOSPHOHYDROLASE
4 12351 KW 3902//ADENOSINE A1 RECEPTOR ANTAGONIST//2 AMP
5 20081 MUCOSAL INFLAMMAT PROGRAM//INFLAMMATION AND INNATE IMMUNITY//HEPATIC OXYGEN CONSUMPTION
6 31866 EHU MED FISIOL POB 699//RABBIT PARIETAL CELLS//ATP ATP ANALOGS
7 3783 P2X7 RECEPTOR//P2X7//P2X7R
8 13855 5 NUCLEOTIDASE//CN II//PYRIMIDINE 5 NUCLEOTIDASE
9 19498 ADENOSINE//ADENOSINE KINASE//5 DEOXY 5 IODOTUBERCIDIN
10 1134 ADENOSINE A2A RECEPTOR//ADENOSINE//A2A RECEPTOR

Go to start page